Alaninaminotransferase and specific viral hepatitis markers in the blood of donors
https://doi.org/10.22416/1382-4376-2018-28-1-50-54
Abstract
Aim of investigation. To study the dynamics of viral hepatitis detection rate after implementation of donors preliminary testing for alanine aminotransferase (ALT) activity. Material and methods. Viral hepatitis markers detection rate by immuno-chemiluminescence assay at testing for ALT activity in venous (n=47080) and capillary (n=22530) blood of donors was studied. Results. Males had higher ALT activity in comparison to that in females, both in venous (for 54.1%), and in capillary (for 27.2%) blood. ALT capillary blood activity was higher on the average, than in venous, for 10.1% in men and 33.3% in women. Conclusions. ALT activity elevation is associated by twofold increase in the rate of lacteous serum and more frequent detection of hepatitis serological markers. In the samples received after capillary blood culling the anti-hepatitis C virus antibodies positivity rate was decreased. No relation of ALT activity to results of parenteral virus genomes screen was revealed.
About the Authors
Zh. K. Burkitbayev
Republican state enterprise with the right of economic management «Scientific-Production Center of Transfusiology»
Russian Federation
Russian Federation
G. A. Yesenbayeva
Republican state enterprise with the right of economic management «Scientific-Production Center of Transfusiology»
Russian Federation
Russian Federation
S. A. Abdrakhmanova
Republican state enterprise with the right of economic management «Scientific-Production Center of Transfusiology»
Russian Federation
Russian Federation
Zh. Zh. Bibekov
Republican state enterprise with the right of economic management «Scientific-Production Center of Transfusiology»
Russian Federation
Russian Federation
Ye. B. Zhiburt
Federal state government-financed institution «Pirogov National Medical and Surgical Center»
Russian Federation
Russian Federation
References
1. Zhiburt E.B., Belgesov N.V., Vaschenko T.N. et al. Alanine aminotransferase is a surrogate marker of viral hepatitis. Vopr virusol 1995; 1(40):25-7.
2. Zhiburt E.B. Study design «The Importance of Screening of Alanine Aminotransferase in donors blood for the Prevention of Post-Transfusion Hepatitis». Transfusiology 2004; 1(5):90-7.
3. Zhiburt E.B. About ALT and not only. Transfusiology 2004; 1(5):102-6.
4. Zhiburt E.B., Abzhueva O.V., Atakishiev M.M. et al. Significance of activity of alanine aminotransferase as a surrogate marker of transfusion-transmitted infections - the results of a national study. Vestnik Sluzby Krovi Rossii 2005; 2:22-7.
5. Zhiburt E.B. Alanine aminotransferase is a surrogate marker of viral hepatitis. Vopr virusol 2005; 6(50):18-20.
6. Zhiburt E.B., Kodenev A.T. Preliminary screening of alanine aminotransferase activity increases the economic efficiency of blood production. Klin labor diagnost 2009; 11:14-6.
7. Golosova S.A., Cherkasov E.G., Popova V.I. et al. Donors blood with increased ALT activity, but with a negative EIA result for viral hepatitis, does not contain these viruses. Top issues hematol transfusiol 2004; 118-9.
8. Filina N.G., Kolotvina T.B., Titova S.A., Zhiburt E.B. Diagnostic significance of alaninaminotransferase detection in donors blood. Transfusiology 2011; 1(12):9-12.
9. Filina N.G., Kolotvina T.B., Titova S.A., Zhiburt E.B. Preliminary screening of blood donor alaninaminotransferase activity has been lost its economical efficacy. Transfusiology 2011; 3(12):61-4.
10. Petrik J., Lozano M., Seed C.R. et al. Hepatitis E. Vox Sang 2016; 1(110):93-103.
11. Tereshchenko Y.A., Tereshchenko S.Y. Asymptomatic increase in serum aminotransferase activity: stages of diagnostic search. Ross z gastroenterol gepatol koloproktol 2014; 1(24):29-38.
12. Приказ и.о. Министра здравоохранения Республики Казахстан от 10 ноября 2009 года № 684 «Об утверждении Правил контроля качества и безопасности донорской крови и ее компонентов».
13. Abdrakhmanova S. The pattern of donor blood rejection after implementation of pre-donation liver transferase screening. Vox Sang 2016; 111(Suppl. 1):149-50.
14. Rommel K., Koch C.D., Spilker D. Influence of specimen withdrawal on the results of chemical analyses of blood, plasma and serum in patients with stable or centralized circulation. J Clin Chem Clin Biochem 1978; 16(7):37380.
15. Haymond R.E., Knight J.A. Venous serum, capillary serum, and capillary plasma compared for use in determination of lactate dehydrogenase and aspartate aminotransferase activities. Clin Chem 1975; 21(7):896-7.
16. Solanki A., Singh A., Chaudhary R. Impact of grey zone sample testing by enzyme-linked immunosorbent assay in enhancing blood safety: Experience at a tertiary care hospital in North India. AJTS 2016; 10(1):71-4.
17. Alter M.J., Kuhnert W.L., Finelli L. Guidelines for laboratory testing and result reporting of antibody to hepatitis C virus. MMWR Recomm Rep 2003; 52(RR-3):1-13, 15; quiz CE1-4.
18. Ivashkin V.T., Herman E.N., Maevskaya M.V. Hidden infection with hepatitis B virus. Ross z gastroenterol gepatol koloproktol 2008; 2(18):4-11.
Review
For citations:
Burkitbayev Zh.K., Yesenbayeva G.A., Abdrakhmanova S.A., Bibekov Zh.Zh., Zhiburt Ye.B. Alaninaminotransferase and specific viral hepatitis markers in the blood of donors. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2018;28(1):50-54. (In Russ.) https://doi.org/10.22416/1382-4376-2018-28-1-50-54
Views:
1167
Email this article 
